CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

NCT00045682 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

NETWORK

Sponsor class

Conditions

Primary Peritoneal Carcinoma
Recurrent Ovarian Carcinoma

Interventions

DRUG: Paclitaxel Poliglumex

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]